430 related articles for article (PubMed ID: 22357707)
1. APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease.
Tzur S; Rosset S; Skorecki K; Wasser WG
Nephrol Dial Transplant; 2012 Apr; 27(4):1498-505. PubMed ID: 22357707
[TBL] [Abstract][Full Text] [Related]
2. Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
Hawkins GA; Friedman DJ; Lu L; McWilliams DR; Chou JW; Sajuthi S; Divers J; Parekh RS; Li M; Genovese G; Pollack MR; Hicks PJ; Bowden DW; Ma L; Freedman BI; Langefeld CD
Am J Nephrol; 2015; 42(2):99-106. PubMed ID: 26343748
[TBL] [Abstract][Full Text] [Related]
3. APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease.
Ma L; Langefeld CD; Comeau ME; Bonomo JA; Rocco MV; Burkart JM; Divers J; Palmer ND; Hicks PJ; Bowden DW; Lea JP; Krisher JO; Clay MJ; Freedman BI
Kidney Int; 2016 Aug; 90(2):389-395. PubMed ID: 27157696
[TBL] [Abstract][Full Text] [Related]
4. The new era of APOL1-associated glomerulosclerosis.
Freedman BI; Langefeld CD
Nephrol Dial Transplant; 2012 Apr; 27(4):1288-91. PubMed ID: 22302261
[No Abstract] [Full Text] [Related]
5. End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.
Freedman BI; Langefeld CD; Andringa KK; Croker JA; Williams AH; Garner NE; Birmingham DJ; Hebert LA; Hicks PJ; Segal MS; Edberg JC; Brown EE; Alarcón GS; Costenbader KH; Comeau ME; Criswell LA; Harley JB; James JA; Kamen DL; Lim SS; Merrill JT; Sivils KL; Niewold TB; Patel NM; Petri M; Ramsey-Goldman R; Reveille JD; Salmon JE; Tsao BP; Gibson KL; Byers JR; Vinnikova AK; Lea JP; Julian BA; Kimberly RP;
Arthritis Rheumatol; 2014 Feb; 66(2):390-6. PubMed ID: 24504811
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation in APOL1 associates with younger age at hemodialysis initiation.
Kanji Z; Powe CE; Wenger JB; Huang C; Ankers E; Sullivan DA; Collerone G; Powe NR; Tonelli M; Bhan I; Bernhardy AJ; Dibartolo S; Friedman D; Genovese G; Pollak MR; Thadhani R
J Am Soc Nephrol; 2011 Nov; 22(11):2091-7. PubMed ID: 21997398
[TBL] [Abstract][Full Text] [Related]
7. African American living-kidney donors should be screened for APOL1 risk alleles.
Cohen DM; Mittalhenkle A; Scott DL; Young CJ; Norman DJ
Transplantation; 2011 Oct; 92(7):722-5. PubMed ID: 21878839
[TBL] [Abstract][Full Text] [Related]
8. Effect of Genetic African Ancestry on eGFR and Kidney Disease.
Udler MS; Nadkarni GN; Belbin G; Lotay V; Wyatt C; Gottesman O; Bottinger EP; Kenny EE; Peter I
J Am Soc Nephrol; 2015 Jul; 26(7):1682-92. PubMed ID: 25349204
[TBL] [Abstract][Full Text] [Related]
9. APOL1 Risk Alleles Are Associated with Exaggerated Age-Related Changes in Glomerular Number and Volume in African-American Adults: An Autopsy Study.
Hoy WE; Hughson MD; Kopp JB; Mott SA; Bertram JF; Winkler CA
J Am Soc Nephrol; 2015 Dec; 26(12):3179-89. PubMed ID: 26038529
[TBL] [Abstract][Full Text] [Related]
10. Hemostatic Factors, APOL1 Risk Variants, and the Risk of ESRD in the Atherosclerosis Risk in Communities Study.
Tin A; Grams ME; Maruthur NM; Astor BC; Couper D; Mosley TH; Fornage M; Parekh RS; Coresh J; Kao WH
Clin J Am Soc Nephrol; 2015 May; 10(5):784-90. PubMed ID: 25887069
[TBL] [Abstract][Full Text] [Related]
11. Gene-gene interactions in APOL1-associated nephropathy.
Divers J; Palmer ND; Lu L; Langefeld CD; Rocco MV; Hicks PJ; Murea M; Ma L; Bowden DW; Freedman BI
Nephrol Dial Transplant; 2014 Mar; 29(3):587-94. PubMed ID: 24157943
[TBL] [Abstract][Full Text] [Related]
12. Analysis of coding variants identified from exome sequencing resources for association with diabetic and non-diabetic nephropathy in African Americans.
Bailey JNC; Palmer ND; Ng MCY; Bonomo JA; Hicks PJ; Hester JM; Langefeld CD; Freedman BI; Bowden DW
Hum Genet; 2014 Jun; 133(6):769-779. PubMed ID: 24385048
[TBL] [Abstract][Full Text] [Related]
13. APOL1 nephropathy risk variants are associated with altered high-density lipoprotein profiles in African Americans.
Gutiérrez OM; Judd SE; Irvin MR; Zhi D; Limdi N; Palmer ND; Rich SS; Sale MM; Freedman BI
Nephrol Dial Transplant; 2016 Apr; 31(4):602-8. PubMed ID: 26152403
[TBL] [Abstract][Full Text] [Related]
14. Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease.
Anyaegbu EI; Shaw AS; Hruska KA; Jain S
Pediatr Nephrol; 2015 Jun; 30(6):983-9. PubMed ID: 25530085
[TBL] [Abstract][Full Text] [Related]
15. Testing for High-Risk APOL1 Alleles in Potential Living Kidney Donors.
Riella LV; Sheridan AM
Am J Kidney Dis; 2015 Sep; 66(3):396-401. PubMed ID: 26049628
[TBL] [Abstract][Full Text] [Related]
16. Increased burden of cardiovascular disease in carriers of APOL1 genetic variants.
Ito K; Bick AG; Flannick J; Friedman DJ; Genovese G; Parfenov MG; Depalma SR; Gupta N; Gabriel SB; Taylor HA; Fox ER; Newton-Cheh C; Kathiresan S; Hirschhorn JN; Altshuler DM; Pollak MR; Wilson JG; Seidman JG; Seidman C
Circ Res; 2014 Feb; 114(5):845-50. PubMed ID: 24379297
[TBL] [Abstract][Full Text] [Related]
17. Association of trypanolytic ApoL1 variants with kidney disease in African Americans.
Genovese G; Friedman DJ; Ross MD; Lecordier L; Uzureau P; Freedman BI; Bowden DW; Langefeld CD; Oleksyk TK; Uscinski Knob AL; Bernhardy AJ; Hicks PJ; Nelson GW; Vanhollebeke B; Winkler CA; Kopp JB; Pays E; Pollak MR
Science; 2010 Aug; 329(5993):841-5. PubMed ID: 20647424
[TBL] [Abstract][Full Text] [Related]
18. Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans.
Hicks PJ; Langefeld CD; Lu L; Bleyer AJ; Divers J; Nachman PH; Derebail VK; Bowden DW; Freedman BI
Kidney Int; 2011 Dec; 80(12):1339-43. PubMed ID: 21849968
[TBL] [Abstract][Full Text] [Related]
19. African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans.
Behar DM; Rosset S; Tzur S; Selig S; Yudkovsky G; Bercovici S; Kopp JB; Winkler CA; Nelson GW; Wasser WG; Skorecki K
Hum Mol Genet; 2010 May; 19(9):1816-27. PubMed ID: 20144966
[TBL] [Abstract][Full Text] [Related]
20. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.
Tzur S; Rosset S; Shemer R; Yudkovsky G; Selig S; Tarekegn A; Bekele E; Bradman N; Wasser WG; Behar DM; Skorecki K
Hum Genet; 2010 Sep; 128(3):345-50. PubMed ID: 20635188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
